YALE UNIVERSITY
Oral digoxin for the treatment of NASH
Oral digoxin for the treatment of NASH is a funding opportunity from YALE UNIVERSITY, up to 609266, closing January 31, 2029.
Jan 31, 2029
(915d left)Overview
Project Summary/ Abstract Nonalcoholic steatohepatitis (NASH) has reached epidemic proportions and will result in an immense burden of chronic liver disease and cirrhosis. Therapeutics for NASH is a very active area of investigation, but even with development of propriety drugs there will be major issues of financial…